Results 61 to 70 of about 726,279 (98)

Cholesterol 7 alpha-hydroxylase (<i>CYP7A1</i>) gene polymorphisms are associated with increased LDL-cholesterol levels and the incidence of subclinical atherosclerosis. [PDF]

Biomol Biomed
Vargas-Alarcón G, Posadas-Sánchez R, Peréz-Méndez O, Fragoso JM.   +3 more
europepmc   +1 more source

Discordance of Low-Density Lipoprotein (LDL) Cholesterol With Alternative LDL-Related Measures and Future Coronary Events

Circulation, 2014
S. Mora, J. Buring, P. Ridker
semanticscholar   +1 more source

Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyond. [PDF]

Am J Prev Cardiol
Safarova M, Bimal T, Soffer DE, Hirsh B, Shapiro MD, Mintz G, Cha A, Gianos E.   +7 more
europepmc   +1 more source

Demographic Predictors of Elevated LDL Cholesterol in Type 1 Diabetes: A Cross-Sectional Study. [PDF]

Clin Diabetes
Dart ME, Patrie JT, Love KM.
europepmc   +1 more source

Investigation of miRNA-199a-5p Expression and its Clinical Association With LDL Cholesterol Levels in Atherosclerosis. [PDF]

In Vivo
Barut Z, Akdeniz FT, Avsar O, Cabbar AT.
europepmc   +1 more source

LDL cholesterol in CKD--to treat or not to treat?

Kidney International, 2013
Z. Massy, D. de Zeeuw
semanticscholar   +1 more source

Direct LDL Cholesterol Assay vs. Estimated Equations in Patients With Hypertriglyceridemia or Low LDL Cholesterol Levels. [PDF]

Ann Lab Med
Rodríguez-Domínguez J, Piedra-Aguilera Á, Martínez-Bujidos M, Malumbres-Serrano S, Morales-Indiano C, Fernández-Prendes C.   +5 more
europepmc   +1 more source

Associations of blood lipids and LDL cholesterol lowering drug-targets with colorectal cancer risk: a Mendelian randomisation study. [PDF]

Br J Cancer
Chan WC, Liu L, Bouras E, Zuber V, Wen W, Long J, Gill D, Murphy N, Gunter MJ, Assimes TL, Bujanda L, Gruber SB, Küry S, Lynch BM, Qu C, Thomas M, White E, Woods MO, Peters U, Li CI, Chan AT, Brenner H, Tsilidis KK, Zheng W.   +23 more
europepmc   +1 more source

Phenolic compounds naturally present in olive oil and lowering of blood LDL-cholesterol and systolic blood pressure, therefore reducing the risk of coronary heart disease: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006. [PDF]

EFSA J
EFSA Panel on Nutrition, Novel Foods and Food allergens (NDA), Turck D, Bohn T, Cámara M, Castenmiller J, de Henauw S, Hirsch-Ernst KI, Jos A, Maciuk A, Mangelsdorf I, McNulty B, Naska A, Pentieva K, Thies F, Drenjančević I, Craciun I, Fiolet T, Siani A.   +18 more
europepmc   +1 more source